Chemical Component Summary

Name2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID
SynonymsSULFASALAZINE
Identifiers2-hydroxy-5-[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl-benzoic acid
FormulaC18 H14 N4 O5 S
Molecular Weight398.39
TypeNON-POLYMER
Isomeric SMILESc1ccnc(c1)NS(=O)(=O)c2ccc(cc2)/N=N/c3ccc(c(c3)C(=O)O)O
InChIInChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+
InChIKeyNCEXYHBECQHGNR-QZQOTICOSA-N

Chemical Details

Formal Charge0
Atom Count42
Chiral Atom Count0
Bond Count44
Aromatic Bond Count18

Drug Info: DrugBank

DrugBank IDDB00795 
NameSulfasalazine
Groupsapproved
DescriptionA drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see mesalamine) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
Synonyms
  • 5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid
  • Salazosulfapyridinum
  • 5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid
  • Salicylazosulfapyridine
  • Sulfasalazina
Brand Names
  • Sulfasalazine Delayed-Release
  • Apo Sulfasalazine Tab 500mg
  • Azulfidine EN-tabs
  • Azulfidine
  • PMS-sulfasalazine-E.C. Tab 500mg
IndicationFor the treatment of Crohn's disease and rheumatoid arthritis as a second-line agent.
Categories
  • Agents causing hyperkalemia
  • Agents that produce hypertension
  • Alimentary Tract and Metabolism
  • Amides
  • Aminosalicylate
ATC-Code
  • G01AE10
  • A07EC01
CAS number599-79-1

Drug Targets

NameTarget SequencePharmacological ActionActions
Arachidonate 5-lipoxygenaseMPSYTVTVATGSQWFAGTDDYIYLSLVGSAGCSEKHLLDKPFYNDFERGA...unknowninhibitor
Prostaglandin G/H synthase 2MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFY...unknowninhibitor
Prostaglandin G/H synthase 1MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGICVRFG...unknowninhibitor
Peroxisome proliferator-activated receptor gammaMGETLGDSPIDPESDSFTDTLSANISQEMTMVDTEMPFWPTNFGISSVDL...unknownagonist
Inhibitor of nuclear factor kappa-B kinase subunit alphaMERPPGLRPGAGGPWEMRERLGTGGFGNVCLYQHRELDLKIAIKSCRLEL...unknowninhibitor
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
CCDC/CSDQIJZOY